Novo Nordisk A/S - The Final Phase 3a Trial for IDegLira

Novo Nordisk A/S - The Final Phase 3a Trial for IDegLira Completed,
and FIAsp Approved for Phase 3 Development 
BAGSVAERD, DENMARK -- (Marketwire) -- 12/19/12 --  Company
Announcement No 83 2012: http://hugin.info/2013/R/1666389/540820.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
that: 
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Novo Nordisk A/S via Thomson Reuters ONE 
[HUG#1666389] 
Novo Nordisk A/S
Novo Alle , DK-2880
Bagsvaerd, Danmark
*T. Tlf. +45 44 44 88 88
*F. Fax +45 44 44 49 05
 
 
Press spacebar to pause and continue. Press esc to stop.